Zacopride
Based on 1 publication(s) in Google Scholar
Zacopride is an orally active 5-HT3 receptor (Ki of 0.38 nM) antagonist and 5-HT4 receptor (Ki of 373 nM) agonist. Zacopride exhibits multiple activities, such as regulating gastrointestinal motility, affecting cardiac function, and exerting anxiolytic and antiemetic effects. Zacopride is currently mainly used in the research of gastrointestinal diseases, cardiovascular diseases, and psychiatric diseases such as anxiety.
For research use only. We do not sell to patients.
- CAS No.: 90182-92-6
- Formula: C15H20ClN3O2
- Molecular Weight:309.79
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Zacopride
MoreAll 5-HT Receptor Isoforms
More
Biological Activity
Zacopride (3-30 μM) reduces the 5-HT-induced maximum contraction response of guinea pig colon in a concentration-dependent mannersup[3].
Zacopride produces 5-HT4 receptor-mediated relaxation of the rat esophagus with an EC50 value of 0.5 μM[3].
Zacopride (10 μM) shortens duration of action potentials in guinea pig isolated papillary muscles[11].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Zacopride (0.1 mg/kg; intraperitoneal injection; single dose) can completely block the vomiting induced by oral administration of 0.1 mg/kg Zacopride in ferrets[4].
Zacopride (0.1 mg/kg; intraperitoneal injection; single dose) can significantly attenuate the increase in extracellular dopamine levels in the nucleus accumbens induced by cocaine in rats[5].
Zacopride (Zacopride chlorhydrate, 1.0 mg/kg; intraperitoneal injection; single dose) combined with Tacrine can improve the accuracy of rats at the shortest delay (0-4 s) in a spatial working memory task[6].
Zacopride (0.01-31.6 mg/kg; p.o.; multiple doses until vomiting occurs) induces vomiting in 100% of ferrets at a cumulative dose of 0.11 mg/kg[7].
Zacopride (0.5 mg/kg; intravenous injection; single dose) combined with Etorphine can alleviate the decrease in respiratory rate caused by Etorphine in goats, increase hemoglobin oxygen saturation and arterial oxygen tension, while reducing carbon dioxide tension and improving ventilation[8].
Zacopride (0.1-1.0 mg/kg; intraperitoneal injection; single dose) exhibits anxiolytic effects in mice (social interaction and elevated plus maze test)[9].
Zacopride (0.0001-10 mg/kg; intraperitoneal injection; single dose) can enhance the exploratory behavior (black-white test box test) and social interaction (social interaction test with rats) of mice[10].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Kuo:Wistar rats (weight: at the beginning of training, 3-month-old rats were used, weight information not specified further), spatial working memory task model[6]
-
Dosage:0.0025-1.0 mg/kg (intraperitoneal, zacopride); 1.0 mg/kg (intraperitoneal, zacopride in combination with tacrine)
-
Administration:Intraperitoneal injection (single dose)
-
Result:Had no significant effect on the percent correct responses in the spatial working memory task at 0.0025-1.0 mg/kg.
Increased the percent correct responses at the shortest delays (0-4 s) but not at the longest delays (8-30 s) when combined with Tacrine (1.0 mg/kg).
Chemical Information
-
CAS No. 90182-92-6
-
Molecular Weight 309.79
-
Formula C15H20ClN3O2
-
SMILES
O=C(C1=C(OC)C=C(N)C(Cl)=C1)NC2CN3CCC2CC3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Front Immunol
TENS alleviates CP/CPPS-related inflammation and pain by modulating Kir2.1-dependent macrophage polarization. [Abstract]2026 Jan 12:16:1683500. PMID: 41624842
Purity & Documentation
References
[1]. Neumann J, et al. Zacopride stimulates 5-HT4 serotonin receptors in the human atrium. Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6821-6835. [Content Brief]
[3]. Nagakura Y, et al. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor. Pharmacol Res. 1999 May;39(5):375-82. [Content Brief]
[4]. Sancilio LF, et al. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents. Eur J Pharmacol. 1990 Jun 8;181(3):303-6. [Content Brief]
[5]. McNeish CS, et al. The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens. Pharmacol Biochem Behav. 1993 Aug;45(4):759-63. [Content Brief]
[6]. Jäkälä P, et al. The effects of tacrine and zacopride on the performance of adult rats in the working memory task. Gen Pharmacol. 1993 May;24(3):675-9. [Content Brief]
[7]. Sancilio LF, et al. Studies on the emetic and antiemetic properties of zacopride and its enantiomers. Eur J Pharmacol. 1991 Jan 17;192(3):365-9. [Content Brief]
[8]. Meyer LC, et al. Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats. Am J Physiol Regul Integr Comp Physiol. 2006 Feb;290(2):R405-13. [Content Brief]
[10]. Costall B, et al. Zacopride: anxiolytic profile in rodent and primate models of anxiety. J Pharm Pharmacol. 1988 Apr;40(4):302-5. [Content Brief]
[11]. Kii Y, et al. Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J Cardiovasc Pharmacol. 1997 May;29(5):670-5. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Zacopride Related Classifications
HY-118317 Related Classifications
Powered by Bioz